These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 476629)

  • 1. Isolation and characterization of canine venereal tumor-associated inhibitory and blocking factors.
    Beschorner WE; Hess AD; Nerenberg ST; Epstein RB
    Cancer Res; 1979 Oct; 39(10):3920-7. PubMed ID: 476629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-blocking and -inhibitory serum factors in the clinical course of canine venereal tumor.
    Bennett BT; Debelak-Fehir KM; Epstein RB
    Cancer Res; 1975 Nov; 35(11 Pt 1):2942-7. PubMed ID: 1182687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and physicochemical characterization of a tumor-associated antigen from canine transmissible venereal sarcoma.
    Palker TJ; Yang TJ
    J Natl Cancer Inst; 1981 Apr; 66(4):779-87. PubMed ID: 6939924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmapheresis as immunotherapeutic modality in the treatment of the canine venereal tumor.
    Zander AR; Sarpell S; Cunningham B; Hess AD; Johnston DA; Epstein RB
    Exp Hematol; 1980 Oct; 8(9):1123-8. PubMed ID: 6164563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of beta 2-microglobulin on the surface of canine transmissible venereal tumor cells.
    Cohen D; Shalev A; Krup M
    J Natl Cancer Inst; 1984 Feb; 72(2):395-401. PubMed ID: 6363791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoelectron microscopic localization of a tumor-associated antigen (TAA) in the canine transmissible venereal sarcoma by anti-TAA-antiferritin hybrid antibodies.
    Hill DL; Yang TJ
    J Natl Cancer Inst; 1985 Oct; 75(4):725-32. PubMed ID: 3900513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunobiology of a spontaneously regressive tumor, the canine transmissible venereal sarcoma (review).
    Yang TJ
    Anticancer Res; 1988; 8(1):93-5. PubMed ID: 3282476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on purification of antibodies against tumor-specific antigens.
    Park MM
    Pahlavi Med J; 1978 Jan; 9(1):1-26. PubMed ID: 652378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cell-mediated immunologic reactivity to Moloney Murine sarcoma virus-induced tumors. III. Further characterization of tumor-specific serum blocking factors.
    Halliday WJ; Koppi TA; McKenzie IF
    J Natl Cancer Inst; 1982 Oct; 69(4):939-44. PubMed ID: 6750199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of leukocyte glass adherence and tube leukocyte adherence inhibition (LAI) reactivity by serum factors in dogs with progressing or spontaneously regressing canine transmissible venereal sarcoma (CTVS).
    Harding MW; Yang TJ
    Cancer Immunol Immunother; 1985; 19(3):168-76. PubMed ID: 3891077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential changes in peripheral blood leukocyte adherence inhibition (LAI) reactivity during progressive growth and spontaneous regression of canine transmissible venereal sarcoma.
    Harding MW; Yang TJ
    Int J Cancer; 1981 Sep; 28(3):361-6. PubMed ID: 7319678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine transmissible venereal tumor (TVT): a review.
    Vermooten MI
    J S Afr Vet Assoc; 1987 Sep; 58(3):147-50. PubMed ID: 3334057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene-expression profiling to identify genes related to spontaneous tumor regression in a canine cancer model.
    Chiang HC; Liao AT; Jan TR; Wang YS; Lei HJ; Tsai MH; Chen MF; Lee CY; Lin YC; Chu RM; Lin CS
    Vet Immunol Immunopathol; 2013 Feb; 151(3-4):207-16. PubMed ID: 23237908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and inhibition of cytotoxic antibody against spontaneous murine breast cancer.
    Stolfi RL; Fugmann RA; Stolfi LM; Martin DS
    J Immunol; 1975 Jun; 114(6):1824-30. PubMed ID: 1127230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of immune complexes in sera of dogs with canine transmissible venereal sarcoma (CTVS) by a conglutinin-binding assay.
    Palker TJ; Yang TJ
    J Comp Pathol; 1985 Apr; 95(2):247-58. PubMed ID: 3915750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic observations on the canine venereal tumor in long-term culture.
    Adams EW; Sapp WJ; Carter LP
    Cornell Vet; 1981 Jul; 71(3):336-46. PubMed ID: 6942961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumoricidal response following perfusion over immobilized protein A: identification of immunoglobulin oligomers in serum after perfusion and their partial characterization.
    Balint J; Ikeda Y; Langone JJ; Shearer WT; Daskal I; Meek K; Cook G; Henry J; Terman DS
    Cancer Res; 1984 Feb; 44(2):734-43. PubMed ID: 6607106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of the acquired immunity in early vertebrates due to danger of transmissible cancers similar to canine venereal tumors.
    Kurbel S; Plestina S; Vrbanec D
    Med Hypotheses; 2007; 68(5):1185-6. PubMed ID: 17110053
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antibodies in venereal sarcoma in dogs].
    Gómez-Estrada H; Hernández-Jauregui P; Arellano-Blanco J; Fernando-Quintero P; Díaz-Esquivel P; Ochoa-Díaz H; Tapia-Arizmendi G
    Arch Invest Med (Mex); 1976; 7(1):1-8. PubMed ID: 1259507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro cell-mediated cytotoxicity and antibody-dependent cellular cytotoxicity to the transmissible venereal tumor of the dog.
    Cohen D
    J Natl Cancer Inst; 1980 Feb; 64(2):317-21. PubMed ID: 6928223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.